Mineralys Therapeutics, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

MLYS

organization

SIC: 2834

SEC Insider

$289.2M

408 transactions

Summary

Mineralys Therapeutics, Inc. (MLYS) is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $142.7MSales: $101.2M22 insiders

Date	Insider	Type	Value
2026-06-26	Warren Eric(Chief Commercial Officer)	Sell	$2.7M
2026-06-30	Congleton Jon(Chief Executive Officer)	Sell	$1.5M
2026-06-26	Warren Eric(Chief Commercial Officer)	M	$1.4M
2026-06-30	Congleton Jon(Chief Executive Officer)	Sell	$456K
2026-06-15	Rodman David Malcom(Chief Medical Officer)	Sell	$235K
2026-06-12	Rodman David Malcom(Chief Medical Officer)	Sell	$152K
2026-06-17	Rodman David Malcom(Chief Medical Officer)	Sell	$115K
2026-06-17	Karydas Daphne	Sell	$75K
2026-06-17	Rodman David Malcom(Chief Medical Officer)	M	$59K
2026-06-15	Rodman David Malcom(Chief Medical Officer)	M	$36K
2026-06-17	Karydas Daphne	M	$36K
2026-06-12	Rodman David Malcom(Chief Medical Officer)	M	$7K
2026-06-17	Rodman David Malcom(Chief Medical Officer)	M	$6K
2026-06-26	Warren Eric(Chief Commercial Officer)	M	$0
2026-06-17	Karydas Daphne	M	$0
2026-06-17	Rodman David Malcom(Chief Medical Officer)	M	$0
2026-06-17	Rodman David Malcom(Chief Medical Officer)	M	$0
2026-06-15	Rodman David Malcom(Chief Medical Officer)	M	$0
2026-06-12	Rodman David Malcom(Chief Medical Officer)	M	$0
2026-06-10	Rodman David Malcom(Chief Medical Officer)	M	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Mineralys Therapeutics, Inc. — Contributions, Lobbying & Contracts | Poliscope